| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 11/11/2009 | EP2116261A1 Sub-region of a plasmodium protein with improved vaccine potential and medical uses thereof |
| 11/11/2009 | EP2116260A1 Screening method for agents suitable for prophylaxis and therapy of Alzheimer's disease (AD) |
| 11/11/2009 | EP2116259A1 TACI-immunoglobulin fusion proteins |
| 11/11/2009 | EP2116258A1 Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease |
| 11/11/2009 | EP2116257A2 Parenteral vaccine formulations and uses thereof |
| 11/11/2009 | EP2116256A1 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same |
| 11/11/2009 | EP2116254A1 Tumor vaccine, a method for producing a tumor vaccine and a method for carrying out antitumor immunotherapy |
| 11/11/2009 | EP2116245A2 EGFR kinase inhibitor combinations for treating respiratory and gastrointestinal disorders |
| 11/11/2009 | EP2115476A2 Methods and biomarkers for diagnosing and monitoring psychotic disorders |
| 11/11/2009 | EP2115134A1 Methods |
| 11/11/2009 | EP2115129A2 Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr) |
| 11/11/2009 | EP2115006A2 Humanized antibodies against cxcr3 |
| 11/11/2009 | EP2115004A2 Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders |
| 11/11/2009 | EP2115003A2 Human antibodies to human delta like ligand 4 |
| 11/11/2009 | EP2115002A2 Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells |
| 11/11/2009 | EP2114998A1 Novel multimeric molecules, method for preparing same and use thereof in the preparation of drugs |
| 11/11/2009 | EP2114996A1 Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens |
| 11/11/2009 | EP2114995A1 Recombinant malaria vaccine |
| 11/11/2009 | EP2114993A1 Vaccine |
| 11/11/2009 | EP2114987A1 Foxp3 peptide vaccine |
| 11/11/2009 | EP2114985A2 Multivariable antigens complexed with targeting humanized monoclonal antibody |
| 11/11/2009 | EP2114459A1 Recombinant viral vectors for prevention and protection against alphavirus infection |
| 11/11/2009 | EP2114456A2 Stabilization of aqueous compositions of proteins with displacement buffers |
| 11/11/2009 | EP2114451A2 Anti-il-13 antibody formulations and uses thereof |
| 11/11/2009 | EP2114449A1 Herpes simplex virus combined subunit vaccines and methods of use thereof |
| 11/11/2009 | EP2114447A1 Prevention and treatment of sub-clinical pcvd |
| 11/11/2009 | EP2114446A1 Vaccine |
| 11/11/2009 | EP2114445A2 Adenoviral vector-based malaria vaccines |
| 11/11/2009 | EP2114444A1 Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins |
| 11/11/2009 | EP2114443A2 Dual-specific il-1a/ il-1b antibodies |
| 11/11/2009 | EP2114442A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 11/11/2009 | EP2114435A1 Modulators of sclerostin binding partners for treating bone-related disorders |
| 11/11/2009 | EP2114426A2 Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from hiv-tat |
| 11/11/2009 | EP2114153A2 Treatment and prevention of neurodegenerative diseases using gene therapy |
| 11/11/2009 | EP1868599B1 Antitumor combination comprising substituted acryloyl distamycin derivatives and antibodies inhibiting growth factors or their receptors |
| 11/11/2009 | EP1664097B1 Piroplasmid vaccine |
| 11/11/2009 | EP1654390B1 Liquid crystal based analyte detection |
| 11/11/2009 | EP1519960B1 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 11/11/2009 | EP1513551B1 Vaccination with immuno-isolated cells producing an immunomodulator |
| 11/11/2009 | EP1482795B1 New immunoeffector compounds |
| 11/11/2009 | EP1450856B1 Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use |
| 11/11/2009 | EP1317278B1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 11/11/2009 | EP1315812B1 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 11/11/2009 | EP1242118B1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 11/11/2009 | EP1191943B1 Anti-allergic peptides |
| 11/11/2009 | EP1181314B1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations |
| 11/11/2009 | CN201342330Y Immunogen emulsifier |
| 11/11/2009 | CN101578298A Ligands that bind IL-4 and/or IL-13 |
| 11/11/2009 | CN101578297A Antibody compositions and methods for treatment of neoplastic disease |
| 11/11/2009 | CN101578296A Human monoclonal antibodies to BTLA and methods of use |
| 11/11/2009 | CN101578113A Anti-KIR antibodies, formulations, and uses thereof |
| 11/11/2009 | CN101578112A PRRSV GP5 based compositions and methods |
| 11/11/2009 | CN101578111A Vaccine for avian influenza and methods of use |
| 11/11/2009 | CN101578110A Treatment of prdc in pigs |
| 11/11/2009 | CN101578109A Poultry vaccine, for necrotic enteritis, comprising a mutated clostridium perfringens alpha toxin antigen, and methods of producing the vaccine |
| 11/11/2009 | CN101578108A Salmonella vaccine in poultry |
| 11/11/2009 | CN101578105A Use of MAGE A3-protein D fusion antigen in immunotherapy combined with surgery, chemotherapy or radiotherapy for the treatment of cancer |
| 11/11/2009 | CN101575607A Recombinant BCG vaccine based on human MUC1 repetitive sequence and GM-CSF fusion expression |
| 11/11/2009 | CN101575606A Clone, expression and application of tender Eimeria tenella protein kinase (EtPK) gene |
| 11/11/2009 | CN101575593A Vaccine for hand-foot-mouth disease and preparation method and application thereof |
| 11/11/2009 | CN101575589A Abortus Brucella vaccine strain S19 marked recombinant strain and application thereof |
| 11/11/2009 | CN101575587A Abortus Brucella vaccine recombinant strain and application thereof in preparing vaccine |
| 11/11/2009 | CN101575586A Bordetella bronchiseptica gene deleted vaccine and application |
| 11/11/2009 | CN101575364A Fresh water fish bacterial gill-rot disease inactivated vaccine |
| 11/11/2009 | CN101575361A Novel specific polypeptide and application thereof in preparing medicament for diagnosing, preventing and treating severe acute respiratory syndrome caused by coronaviruses |
| 11/11/2009 | CN101574520A Methods of administering anti-TNF alpha antibodies |
| 11/11/2009 | CN101574519A Method for preventing or treating opiate resistance and dependency |
| 11/11/2009 | CN101574518A Hapten-carrier conjugates and uses thereof |
| 11/11/2009 | CN101574517A Adjuvant-free immunity regulating agent for preventing and treating type 1 diabetes |
| 11/11/2009 | CN101574516A Triple vaccine of bacterial gill-rot, sepsis and red-skin diseases of grass carps and preparation method thereof |
| 11/11/2009 | CN100558903C Photochemical internalization for delivery of molecules into the cytosol |
| 11/11/2009 | CN100558895C The anti-platelet membrane glycoprotein VI monoclonal antibody |
| 11/11/2009 | CN100558894C Synthetic gene encoding human epidermal growth factor 2/NEU antigen and uses thereof |
| 11/11/2009 | CN100558401C Adjuvant systems and vaccines |
| 11/11/2009 | CN100558400C Pharmaceutical composition for inducing an immune response in a human or animal |
| 11/11/2009 | CN100558399C Vaccine comprising a tick cement protein |
| 11/11/2009 | CN100558395C Hybrid peptide modulate immune response |
| 11/10/2009 | US7615679 Method of producing polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 11/10/2009 | US7615616 Detecting cell wall anchored surface proteins and developing vaccines to diagnose, prevent and treat enterococcus, streptococcus, staphylococcus and bacillus infections |
| 11/10/2009 | US7615615 Modified interferon beta with reduced immunogenicity |
| 11/10/2009 | US7615614 Antigen constructs useful in the detection and differentiation of antibodies to HIV |
| 11/10/2009 | US7615613 Antigen constructs useful in the detection and differentiation of antibodies to HIV |
| 11/10/2009 | US7615612 Vaccine composition comprising non-human, mammalian 5T4 antigen for prevention of cell proliferative disorders |
| 11/10/2009 | US7615533 Peptide compounds derivatized with a hydrophilic polymer; solubility and circulation half-lives are increased and their immunogenicity is masked |
| 11/10/2009 | US7615383 Methods for treating neuropathy by agonist anti-trk-C monoclonal antibodies |
| 11/10/2009 | US7615379 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer |
| 11/10/2009 | US7615229 useful in inducing a protective immune response against NTHi in an immunized human |
| 11/10/2009 | US7615228 Chimeric protein containing specific polypeptide and a conserved fragment of hemagglutin antigen from influenza virus |
| 11/10/2009 | US7615227 Using cytosine and guanine oligonucleotide as activators of neovascularization; for use in tissue repair and grafting |
| 11/10/2009 | US7615226 Antigen is mixed with at antigen is mixed with at least one adjuvant and the mixture subsequently is heat-treated |
| 11/10/2009 | US7615225 Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen |
| 11/10/2009 | US7615224 Multiplex-bead complex for determination of lysosomal storage disorders |
| 11/10/2009 | US7615223 antibody, immunoconjugate and duramycin-based compositions; bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases |
| 11/10/2009 | US7615222 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
| 11/10/2009 | US7615221 Compositions and methods for treating cancer |
| 11/10/2009 | US7615220 High affinity human antibodies to human IL-18 receptor |
| 11/10/2009 | US7615219 Treatment of decreased blood platelet numbers by neutralizing anti-PACAP antibody or antigen-binding fragment; haemostasis |
| 11/10/2009 | US7615218 Methods for determining and lowering caffeine concentration in fluids |
| 11/10/2009 | US7615217 Modified fusion protein comprising an anti-EGFR immunoglobulin moiety and a cytokine polypeptide moiety linked together |
| 11/10/2009 | US7615216 For treating immunosuppressive diseases; AIDS |